Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi lifts lid on MS data behind tolebrutinib’s mixed phase 3 scorecard, plans ‘24 approval filings
Fierce Biotech
Fri, 09/20/24 - 10:15 am
Sanofi
tolebrutinib
clinical trials
MS
multiple sclerosis
Sanofi readies to meet US demand for RSV antibody
BioPharma Dive
Mon, 09/16/24 - 10:17 pm
Sanofi
AstraZeneca
Beyfortus
RSV
antibodies
Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis
Fierce Biotech
Thu, 09/12/24 - 11:35 am
Sanofi
radioligands
neuroendocrine tumors
RadioMedix
Orano Med
AlphaMedix
Sanofi's innovative medicine production site inaugurated in France
European Pharmaceutical Review
Wed, 09/11/24 - 11:04 pm
Sanofi
France
drug manufacturing
biologics
vaccines
3 FDA approval dates to watch in the year’s final push
Pharma Voice
Wed, 09/11/24 - 11:39 am
FDA
Bristol Myers Squibb
KarXT
schizophrenia
Regeneron
Sanofi
Dupixent
COPD
BridgeBio
acoramidis
ATTR cardiomyopathy
Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
BioPharma Dive
Wed, 09/11/24 - 11:19 am
Dupixent
chronic hives
Sanofi
Regeneron
FDA
Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
protein degradation
Arvinas
Merck KGaA
Sanofi
Pfizer
Novartis
Sanofi finds a silver lining in mixed MS drug results
BioPharma Dive
Tue, 09/3/24 - 05:50 pm
Sanofi
tolebrutinib
MS
multiple sclerosis
clinical trials
Sanofi's mixed fortunes in MS drug trials has market focus on win
Reuters
Mon, 09/2/24 - 12:11 pm
Sanofi
multiple sclerosis
MS
clinical trials
tolebrutinib
Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal
BioSpace
Fri, 08/2/24 - 11:31 am
Vir Biotechnology
layoffs
Sanofi
cancer
virology
Sanofi to invest 1.3 bln euros in new insulin plant in Frankfurt
Reuters
Thu, 08/1/24 - 11:53 am
Sanofi
drug manufacturing
Frankfurt
Germany
insulin
Sanofi sues Sarepta, claiming Duchenne gene therapy Elevidys infringes 2 manufacturing patents
Fierce Pharma
Tue, 07/30/24 - 06:35 pm
Sarepta Therapeutics
Sanofi
legal
patents
Elevidys
DMD
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run
Pharma Voice
Tue, 07/30/24 - 11:30 am
Sanofi
Regeneron
Dupixent
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Reuters
Thu, 07/25/24 - 11:26 am
Sanofi
Dupixent
earnings
Sanofi to more than double its workforce at Hyderabad site with $437M expansion: reports
Fierce Pharma
Wed, 07/17/24 - 12:11 pm
Sanofi
India
Hyderabad
Flu vaccine makers CSL Seqirus, Sanofi and GSK kick off initial shipments ahead of upcoming season
Fierce Pharma
Thu, 07/11/24 - 11:35 am
flu vaccines
CSL Seqirus
Sanofi
GSK
vaccines
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says
Reuters
Mon, 07/1/24 - 11:11 am
Sanofi
insulin
drug manufacturing
Germany
Sanofi reports findings from Phase II relapsing MS treatment trial
Clinical Trials Arena
Mon, 07/1/24 - 11:00 am
Sanofi
frexalimab
relapsing multiple sclerosis
MS
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »